Gyre Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.About GYRE
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis).
CEOPing Zhang
CEOPing Zhang
Employees5
Employees5
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1997
Founded1997
Employees5
Employees5
GYRE Key Statistics
Market cap759.11M
Market cap759.11M
Price-Earnings ratio200.52
Price-Earnings ratio200.52
Dividend yield—
Dividend yield—
Average volume48.28K
Average volume48.28K
High today$7.90
High today$7.90
Low today$7.50
Low today$7.50
Open price$7.64
Open price$7.64
Volume44.03K
Volume44.03K
52 Week high$14.42
52 Week high$14.42
52 Week low$6.11
52 Week low$6.11
Stock Snapshot
Gyre Therapeutics(GYRE) stock is priced at $7.90, giving the company a market capitalization of 759.11M. It carries a P/E multiple of 200.52.
On 2025-12-04, Gyre Therapeutics(GYRE) stock traded between a low of $7.50 and a high of $7.90. Shares are currently priced at $7.90, which is +5.3% above the low and 0.0% below the high.
The Gyre Therapeutics(GYRE)'s current trading volume is 44.03K, compared to an average daily volume of 48.28K.
During the past year, Gyre Therapeutics(GYRE) stock moved between $6.11 at its lowest and $14.42 at its peak.
During the past year, Gyre Therapeutics(GYRE) stock moved between $6.11 at its lowest and $14.42 at its peak.
People also own
Based on the portfolios of people who own GYRE. This list is generated using Robinhood data, and it’s not a recommendation.